Anti-hypernociceptive properties of agmatine in persistent inflammatory and neuropathic models of pain in mice

Brain Research

Volumn 1159, Issue 1, 2007, Pages 124-133

  Paszcuk, Ana Flávia ^a   Gadotti, Vinicius M ^a   Tibola, Daiane ^a   Quintão, Nara L M ^a   Rodrigues, Ana Lúcia S ^a   Calixto, João B ^a   Santos, Adair R S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Agmatine; Antinociception; Cytokines; Inflammatory chronic pain; Neuropathic pain

Indexed keywords

AGMATINE; FREUND ADJUVANT; MYELOPEROXIDASE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD SENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; MALE; MONONEUROPATHY; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; SCIATIC NERVE;

AGMATINE; ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CYTOKINES; DISEASE MODELS, ANIMAL; EDEMA; FEMALE; FREUND'S ADJUVANT; INFLAMMATION; MICE; NEUTROPHILS; PAIN; PAIN MEASUREMENT; PEROXIDASE; SCIATIC NEUROPATHY;

MUS;

EID: 34447573699     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.050     Document Type: Article

References (63)

1. Aricioglu-Kartal F., and Altunbas H. Is agmatine an endogenous anxiolitic/antidepressant agent?. Ann. N.Y. Acad. Sci. 1009 (2003) 136-140
2. Aricioglu-Kartal F., Kan B., Yillar O., Korcegez E., and Berkman K. Effect of agmatine on electrically and chemically induced seizures in mice. Ann. N.Y. Acad. Sci. 1009 (2003) 141-146
3. Aricioglu-Kartal F., Korcegez E., Bozkurt A., and Ozyalcin S. Effect of agmatine on acute and mononeuropathic pain. Ann. N.Y. Acad. Sci. 1009 (2003) 105-115
4. Askalany A.R., Yamakura T., Petrenko A.B., Kohno T., Sakimura K., and Baba H. Effect of agmatine on heteromeric N-methyl-d-aspartate receptor channels. Neurosci. Res. 52 (2005) 387-392
5. Basbaum A.I. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med. 24 (1999) 59-67
6. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
7. Besson J.M. The neurobiology of pain. Lancet 353 (1999) 1610-1615
8. Bortolanza L.B., Ferreira J., Hess S.C., Delle Monache F., Yunes R.A., and Calixto J.B. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur. J. Pharmacol. 25 (2002) 203-208
9. Carraway M.S., Welty-Wolf K.E., Miller D.L., Ortel T.L., Idell S., Ghio A.J., Petersen L.C., and Piantadosi C.A. Blockade of tissue factor: treatment for organ injury in established sepsis. Am. J. Respir. Crit. Care Med. 167 (2003) 1200-1209
10. Chan C.F., Sun W.Z., Lin J.K., and Lin-Shiau S.Y. Activation of transcription factors of nuclear factor kappa B activator protein-1 and octamer factors in hyperalgesia. Eur. J. Pharmacol. 42 (2000) 61-68
11. Chu Y.C., Guan Y., Skinner J., Raja S.N., Johns R.A., and Tao Y.X. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 119 (2005) 113-123
12. Cui J.G., Holmin S., Mathiesen T., Meyerson B.A., and Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88 (2000) 239-248
13. Cunha T.M., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1755-1760
14. Dickenson A.H., Chapman V., and Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol. 28 (1997) 633-638
15. Eliav E., Herzberg U., and Caudle R.M. The kappa opioid agonist GR89696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy. Pain 79 (1999) 255-264
16. Fairbanks C.A., Schreider K.L., Brewer C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholki D.W., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., and Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10584-10589
17. Feng Y., LeBlanc M.H., and Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci. Lett. 390 (2005) 129-133
18. Ferreira J., Campos M.M., Pesquero J.B., Araujo R.C., and Calixto J.B. Evidence for the participation of kinins in Freund's adjuvant induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology 41 (2001) 1006-1012
19. Fundytus M.E. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15 (2001) 29-58
20. Gadotti V.M., Tibola D., Paszcuk A.F., Rodrigues A.L.S., Calixto J.B., and Santos A.R.S. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Brain Res. 1093 (2006) 116-122
21. Galea E., Regunathan S., Eliopoulos U., Feinstein D.L., and Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316 (1996) 247-249
22. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
23. Horvath G., Kekesi G., Dobos I., Szikszay M., Klimscha W., and Benedek G. Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. Eur. J. Pharmacol. 368 (1999) 197-204
24. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
25. Karadag H.C., Ulugol A., Tamer M., Ipci Y., and Dokmeci I. Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats. Neurosci. Lett. 339 (2003) 88-90
26. Kleinschnitz C., Brinkhoff J., Zelenka M., Sommer C., and Stoll G. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J. Neuroimmunol. 149 (2004) 77-83
27. Lavinsky D., Arteni N.S., and Netto C.A. Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav. Brain Res. 141 (2003) 19-24
28. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
29. Loring R.H. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol. 99 (1990) 207-211
30. Malmberg A.B., and Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioural and neuroanatomical correlates. Pain 76 (1998) 215-222
31. Mao J., Price D.D., Mayer D.J., Lu J., and Hayes R.L. Intrathecal MK801 and local nerve anesthesia synergistically reduce nociceptive behaviours in rats with experimental peripheral mononeuropathy. Brain Res. 576 (1992) 254-262
32. McKay B.E., Lado W.E., Martin L.J., Galic M.A., and Fournier N.M. Learning and memory in agmatine-treated rats. Pharmacol. Biochem. Behav. 72 (2002) 551-557
33. Minami M., Katayama T., and Satoh M. Brain cytokines and chemokines: roles in ischemic injury and pain. J. Pharmacol. Sci. 100 (2006) 461-470
34. Myers R.R., Campana W.M., and Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today 11 (2006) 8-20
35. Olmos G., DeGregorio-Rocasolano N., Paz Regalado M., Gasull T., Assumpcio Boronat M., Trullas R., Villarroel A., Lerma J., and Garcia-Sevilla J.A. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol. 127 (1999) 1317-1326
36. Önal A., and Soykan N. Agmatine produces antinociception in tonic pain in mice. Pharmacol. Biochem. Behav. 69 (2001) 93-97
37. Önal A., Dlen Y., Ülker S., and Soykan N. Agmatine attenuates neuropathic pain: Possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci. 73 (2003) 413-428
38. Posadas I., Bucci M., Roviezzo F., Rossi A., Parente L., Sautebin L., and Cirino G. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br. J. Pharmacol. 142 (2004) 331-338
39. Raasch W., Schafer U., Chun J., and Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline biding sites. Br. J. Pharmacol. 133 (2001) 755-780
40. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20 (2004) 467-473
41. Regunathan S. Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence. AAPS J. 21 (2006) 479-484
42. Regunathan S., and Piletz J.E. Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann. N.Y. Acad. Sci. 1009 (2003) 20-29
43. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 21 (2000) 187-193
44. Robertson B., Xu X.J., Hao J.X., Wiesenfeld-Hallin Z., Mhlanga J., Grant G., and Kristensson K. Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. NeuroReport 8 (1997) 1311-1316
45. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., and Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
46. Santos A.R.S., Gadotti V.M., Oliveira G.L., Tibola D., Paszcuk A.F., Neto A., Spindola H.M., Souza M.M., Rodrigues A.L.S., and Calixto J.B. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 48 (2005) 1021-1034
47. Sommer C., and Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361 (2004) 184-187
48. Souza D.G., Coutinho S.F., Silveira M.R., Cara D.C., and Teixeira M.M. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur. J. Pharmacol. 403 (2000) 121-128
49. Tadano T., Namioka M., Nakagawasai O., Tan-No K., Matsushima K., Endo Y., and Kisara K. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. Life Sci. 65 (1999) 255-261
50. Tracey D.J., and Walker J.S. Pain due to nerve damage: are inflammatory mediators involved?. Inflamm. Res. 44 (1995) 407-411
51. Verri Jr. W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., and Ferreira S.H. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol. Ther. 112 (2006) 116-138
52. Yang X.C., and Reis D.J. Agmatine selectively blocks the NMDA subclass of glutamate receptor channels in cultured mouse hipocampal neurons. J. Pharmacol. Exp. Ther. 288 (1999) 544-549
53. Yoshimura M., and Yonehara N. Alteration in sensitivity of ionotropic glutamate receptors and tachykinin receptors in spinal cord contribute to development and maintenance of nerve injury-evoked neuropathic pain. Neurosci. Res. 56 (2006) 21-28
54. Wang W.P., Iyo A.H., Miguel-Hidalgo J., Regunathan S., and Zhu M.Y. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res. 1084 (2006) 210-216
55. Wolf C., Bruess M., Haenisch B., Goethert, M., von Kuegelgen I., and Molderings G.J. Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic and neuronal origin. Mol. Pharmacol. 71 (2007) 276-283
56. Woolf C.J., and Mannion R.J. Neuropathic pain: etiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
57. Woolf C.J., and Salter M.W. Neuronal plasticity: Increasing the gain in pain. Science 288 (2000) 1765-1769
58. Woolf C.J., and Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
59. Zhu M.Y., Wang W.P., and Bissette G. Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 141 (2006) 2019-2027
60. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animal. Pain 16 (1983) 109-111
61. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429 (2001) 23-37
62. Zomkowski A.D., Hammes L., Lin J., Calixto J.B., Santos A.R.S., and Rodrigues A.L.S. Agmatine produces antidepressant-like effects in two models of depression in mice. NeuroReport 13 (2002) 387-391
63. Zomkowski A.D., Santos A.R.S., and Rodrigues A.L.S. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci. Lett. 381 (2005) 279-283